Iridex to Present at the 35th Annual Roth Conference
March 07 2023 - 4:05PM
Iridex Corporation (Nasdaq: IRIX), a provider of innovative
ophthalmic laser-based medical products for the treatment of
glaucoma and retinal diseases, today announced plans to participate
in the upcoming 35th Annual Roth Conference in Laguna Niguel, CA.
Management is scheduled to present on Tuesday, March 14 at 11:00
am PT. Interested parties may access a live and archived webcast of
the presentation on the “Event Calendar” page of the “Investors”
section of the company’s website at www.IRIDEX.com.
About IridexIridex Corporation is a
worldwide leader in developing, manufacturing, and marketing
innovative and versatile laser-based medical systems, delivery
devices and consumable instrumentation for the ophthalmology
market. The Company’s proprietary MicroPulse® technology delivers a
differentiated treatment that provides safe, effective, and proven
treatment for targeted sight-threatening eye conditions. Iridex’s
current product line is used for the treatment of glaucoma and
diabetic macular edema (DME) and other retinal diseases. Iridex
products are sold in the United States through a direct sales force
and internationally primarily through a network of independent
distributors into more than 100 countries. For further information,
visit the Iridex website at www.iridex.com.
Investor Relations ContactPhilip
Taylorinvestors@iridex.com
IRIDEX (NASDAQ:IRIX)
Historical Stock Chart
From Jul 2024 to Aug 2024
IRIDEX (NASDAQ:IRIX)
Historical Stock Chart
From Aug 2023 to Aug 2024